Anna L Hotton1, Kathleen M Weber, Ronald C Hershow, Kathryn Anastos, Peter Bacchetti, Elizabeth T Golub, Deborah Gustafson, Alexandra M Levine, Mary Young, Mardge H Cohen. 1. *The CORE Center, Cook County Health and Hospitals System, Chicago, IL; †Division of Epidemiology and Biostatistics, University of Illinois at Chicago, School of Public Health, Chicago, IL; ‡Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY; §Division of Biostatistics, University of California San Francisco, San Francisco, CA; ‖Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; ¶Downstate Medical Center, State University of New York, Brooklyn, NY; #City of Hope National Medical Center, Duarte, CA and the Keck School of Medicine, University of Southern California, Los Angeles, CA; **Division of Infectious Diseases, Georgetown University Medical Center, Washington, DC; and ††Departments of Medicine, Stroger Hospital and Rush University Medical Center, Chicago, IL.
Abstract
OBJECTIVES: We evaluated the Veterans Aging Cohort Study (VACS) Index score, an index composed of age, CD4 count, viral load, hemoglobin, Hepatitis C coinfection, Fibrosis Index-4, and estimated glomerular filtration rate, and psychosocial and clinical risk factors for all-cause hospitalization among HIV-infected women on highly active antiretroviral therapy and HIV-uninfected women. METHODS: Data were collected from 2008 to 2014 from 1585 highly active antiretroviral therapy-experienced HIV infected and 692 uninfected women. Cox proportional hazards regression evaluated predictors of first hospitalization over 2 years. RESULTS: Among HIV-infected women, VACS Index score (per 5 points) [adjusted hazard ratio (aHR) 1.08; 95% confidence interval (CI): 1.06 to 1.11], Centers for Epidemiologic Studies-Depression (CESD) scores ≥16 (aHR 1.61; 95% CI: 1.30 to 1.99), smoking (aHR 1.26; 95% CI: 1.02 to 1.55), abuse history (aHR 1.52; 95% CI: 1.20 to 1.93), diabetes (aHR 1.63; 95% CI: 1.31 to 2.04), and black race (aHR 1.28; 95% CI: 1.03 to 1.59) increased risk of hospitalization. Among HIV-uninfected women, VACS Index score (aHR 1.08; 95% CI: 1.03 to 1.13), CESD scores ≥16 (aHR 1.38; 95% CI: 1.02 to 1.86), diabetes (aHR 2.15; 95% CI: 1.57 to 2.95), and black race (aHR 1.61; 95% CI: 1.15 to 2.24) predicted subsequent hospitalization. CONCLUSIONS: Psychosocial and clinical factors were associated with risk of hospitalization independently of the VACS Index score. Additional research on contextual and psychosocial influences on health outcomes among women is needed.
OBJECTIVES: We evaluated the Veterans Aging Cohort Study (VACS) Index score, an index composed of age, CD4 count, viral load, hemoglobin, Hepatitis C coinfection, Fibrosis Index-4, and estimated glomerular filtration rate, and psychosocial and clinical risk factors for all-cause hospitalization among HIV-infectedwomen on highly active antiretroviral therapy and HIV-uninfectedwomen. METHODS: Data were collected from 2008 to 2014 from 1585 highly active antiretroviral therapy-experienced HIV infected and 692 uninfected women. Cox proportional hazards regression evaluated predictors of first hospitalization over 2 years. RESULTS: Among HIV-infectedwomen, VACS Index score (per 5 points) [adjusted hazard ratio (aHR) 1.08; 95% confidence interval (CI): 1.06 to 1.11], Centers for Epidemiologic Studies-Depression (CESD) scores ≥16 (aHR 1.61; 95% CI: 1.30 to 1.99), smoking (aHR 1.26; 95% CI: 1.02 to 1.55), abuse history (aHR 1.52; 95% CI: 1.20 to 1.93), diabetes (aHR 1.63; 95% CI: 1.31 to 2.04), and black race (aHR 1.28; 95% CI: 1.03 to 1.59) increased risk of hospitalization. Among HIV-uninfectedwomen, VACS Index score (aHR 1.08; 95% CI: 1.03 to 1.13), CESD scores ≥16 (aHR 1.38; 95% CI: 1.02 to 1.86), diabetes (aHR 2.15; 95% CI: 1.57 to 2.95), and black race (aHR 1.61; 95% CI: 1.15 to 2.24) predicted subsequent hospitalization. CONCLUSIONS:Psychosocial and clinical factors were associated with risk of hospitalization independently of the VACS Index score. Additional research on contextual and psychosocial influences on health outcomes among women is needed.
Authors: Charles H Hinkin; Terry R Barclay; Steven A Castellon; Andrew J Levine; Ramani S Durvasula; Sarah D Marion; Hector F Myers; Douglas Longshore Journal: AIDS Behav Date: 2007-03
Authors: María J Marquine; Anya Umlauf; Alexandra S Rooney; Pariya L Fazeli; Ben D Gouaux; Steven Paul Woods; Scott L Letendre; Ronald J Ellis; Igor Grant; David J Moore Journal: J Acquir Immune Defic Syndr Date: 2014-02-01 Impact factor: 3.731
Authors: Mardge H Cohen; Anna L Hotton; Ronald C Hershow; Alexandra Levine; Peter Bacchetti; Elizabeth T Golub; Kathryn Anastos; Mary Young; Deborah Gustafson; Kathleen M Weber Journal: J Acquir Immune Defic Syndr Date: 2015-12-15 Impact factor: 3.731
Authors: Julie A Womack; Joseph L Goulet; Cynthia Gibert; Cynthia A Brandt; Melissa Skanderson; Barbara Gulanski; David Rimland; Maria C Rodriguez-Barradas; Janet Tate; Michael T Yin; Amy C Justice Journal: Clin Infect Dis Date: 2013-02-01 Impact factor: 9.079
Authors: Jane Leserman; Brian Wells Pence; Kathryn Whetten; Michael J Mugavero; Nathan M Thielman; Marvin S Swartz; Dalene Stangl Journal: Am J Psychiatry Date: 2007-11 Impact factor: 18.112
Authors: Kathleen M Akgün; Kirsha Gordon; Margaret Pisani; Terri Fried; Kathleen A McGinnis; Janet P Tate; Adeel A Butt; Cynthia L Gibert; Laurence Huang; Maria C Rodriguez-Barradas; David Rimland; Amy C Justice; Kristina Crothers Journal: J Acquir Immune Defic Syndr Date: 2013-01-01 Impact factor: 3.731
Authors: Sophia M Rein; Colette J Smith; Clinton Chaloner; Adam Stafford; Alison J Rodger; Margaret A Johnson; Jeffrey McDonnell; Fiona Burns; Sara Madge; Alec Miners; Lorraine Sherr; Simon Collins; Andrew Speakman; Andrew N Phillips; Fiona C Lampe Journal: EClinicalMedicine Date: 2020-12-01
Authors: Yuhang Qian; Richard D Moore; Sally B Coburn; Thibaut Davy-Mendez; Kathleen M Akgün; Kathleen A McGinnis; Michael J Silverberg; Jonathan A Colasanti; Edward R Cachay; Michael A Horberg; Charles S Rabkin; Jeffrey M Jacobson; M John Gill; Angel M Mayor; Gregory D Kirk; Kelly A Gebo; Ank E Nijhawan; Keri N Althoff Journal: J Acquir Immune Defic Syndr Date: 2022-01-01 Impact factor: 3.771
Authors: Jessica L Castilho; Peter F Rebeiro; Bryan E Shepherd; Robertson Nash; Rodney S Adams; Megan Turner; Sally S Furukawa; Todd Hulgan; John R Koethe; Timothy R Sterling Journal: J Acquir Immune Defic Syndr Date: 2020-04-01 Impact factor: 3.771
Authors: Sophia M Rein; Fiona C Lampe; Margaret A Johnson; Sanjay Bhagani; Robert F Miller; Clinton Chaloner; Andrew N Phillips; Fiona M Burns; Colette J Smith Journal: AIDS Date: 2021-02-02 Impact factor: 4.632